Anzeige
Mehr »
Montag, 08.09.2025 - Börsentäglich über 12.000 News
Tokenisierung entfesselt: Republic führt die Ethereum-Revolution
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1CY7H | ISIN: IL0010951403 | Ticker-Symbol:
NASDAQ
08.09.25 | 21:47
2,260 US-Dollar
-0,44 % -0,010
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SCISPARC LTD Chart 1 Jahr
5-Tage-Chart
SCISPARC LTD 5-Tage-Chart

Aktuelle News zur SCISPARC

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22:00SciSparc Ltd. - 6-K, Report of foreign issuer2
28.08.SciSparc Ltd: SciSparc: AutoMax's Shareholders Approve Merger with SciSparc124TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
► Artikel lesen
28.08.SciSparc Ltd: SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel89TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
► Artikel lesen
25.08.SciSparc Ltd. - 6-K, Report of foreign issuer1
09.08.SPRC Announces THB0.15 Dividend Payment following 2Q25 Earnings Report-
08.08.SciSparc Ltd. - 6-K, Report of foreign issuer1
SCISPARC Aktie jetzt für 0€ handeln
07.08.SciSparc Ltd: SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar1
31.07.Miza III Ventures Inc: Miza extends outside date of SciSparc LOI to Oct. 312
31.07.SciSparc Ltd. - 6-K, Report of foreign issuer-
30.07.SciSparc Ltd: SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC112TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
► Artikel lesen
30.07.SciSparc Ltd: SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease231TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
► Artikel lesen
22.07.SciSparc Ltd. - 6-K, Report of foreign issuer1
22.07.SciSparc regains compliance with Nasdaq's listing rule1
22.07.SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification140Tel Aviv, July 22, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. ("SciSparc" or the "Company") (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to...
► Artikel lesen
16.07.SPRC Names Herbert Matthew Payne II as New CEO and Director1
24.06.SciSparc kündigt 1:21-Aktienzusammenlegung für den 3. Juli an2
24.06.SciSparc to implement 1-for-21 reverse share split; shares down1
24.06.SciSparc Ltd: SciSparc Announces 1-for-21 Reverse Share Split339Tel Aviv, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. ("SciSparc" or the "Company") (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
► Artikel lesen
24.06.SciSparc Ltd. - 6-K, Report of foreign issuer4
09.06.SciSparc Ltd. - 6-K, Report of foreign issuer2
Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1